CG-690

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCG-690
Drug Alias NameClaragen-TOPrecombinant human CC10 (Clarassance)recombinant human uteroglobin (Clarassance)CG-690
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionSecretoglobin family 1A member 1 stimulants
TargetsSecretoglobin family 1A member 1
Therapy Area/IndicationsPsoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTherabron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherabron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A